Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome-Reference-Cited by-同舟云学术

Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome

Published:2019-06-11 Issue:9 Volume:23 Page:1154-1160
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Kondoh Tomomi,Ikezumi Yohei^ORCID,Yokoi Katsuyuki,Nakajima Yoko,Matsumoto Yuji,Kaneko Masahiro,Hasegawa Hiroya,Yamada Takeshi,Kumagai Naonori,Ito Tetsuya,Yoshikawa Tetsushi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-019-01754-1.pdf

Reference21 articles.

1. Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018;392(10141):61–74.

2. Larkins N, Kim S, Craig J, Hodson E. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child. 2016;101:404–8.

3. Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, et al. Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2014;384(9950):1273–81.

4. Fujinaga S, Hirano D, Nishizaki N, Someya T, Ohtomo Y, Ohtsuka Y, et al. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration. Pediatr Nephrol. 2011;26:479–83.

5. Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H. Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2005;20:96–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroid Sensitive Nephrotic Syndrome;Pediatric Kidney Disease;2023

2. Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent;The Tohoku Journal of Experimental Medicine;2022

3. Steroid-Sensitive Nephrotic Syndrome;Pediatric Nephrology;2022

4. Steroid-Sensitive Nephrotic Syndrome;Pediatric Nephrology;2021